General Information of the Compound
Compound ID |
CP0283744
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
ABT-670
Show/Hide
|
||||||||||||||||||
Synonyms |
3-methyl-N-[[4-(1-oxidopyridin-1-ium-2-yl)piperidin-1-yl]methyl]benzamide
3-methyl-n-(1-oxy-3',4',5',6'-tetrahydro-2'h-(2,4'-bipyridine)-1'-ylmethyl)benzamide
4L6071XH2J
630119-43-6
ABT 670
ABT-670
ABT670
BDBM50200050
Benzamide, 3-methyl-N-[[4-(1-oxido-2-pyridinyl)-1-piperidinyl]methyl]-
CHEMBL219182
CS-6805
CTK2B0090
DTXSID30212235
GTPL8439
HY-19483
SCHEMBL4010523
UNII-4L6071XH2J
ZINC35075418
compound 6b [PMID 17149874]
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C19H23N3O2
|
||||||||||||||||||
Molecular Weight |
325.412
|
||||||||||||||||||
Canonical SMILES |
Cc1cccc(c1)C(=O)NCN1CCC(CC1)c1cccc[n+]1[O-]
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C19H23N3O2/c1-15-5-4-6-17(13-15)19(23)20-14-21-11-8-16(9-12-21)18-7-2-3-10-22(18)24/h2-7,10,13,16H,8-9,11-12,14H2,1H3,(H,20,23)
Show/Hide
|
||||||||||||||||||
InChIKey |
PUMMPCXNEPHBNN-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound